• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MERZ NORTH AMERICA RADIESSE+ DERMAL FILLER; INJECTABLE IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MERZ NORTH AMERICA RADIESSE+ DERMAL FILLER; INJECTABLE IMPLANT Back to Search Results
Device Problem No Apparent Adverse Event (3189)
Patient Problems Cellulitis (1768); Obstruction/Occlusion (2422)
Event Type  Injury  
Manufacturer Narrative
This case was assessed as reportable to the fda as the event was deemed to meet serious injury criteria of necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure.Additionally, the device was assessed as possibly causing or contributing to the event.The lot number was not reported.The reported events of suspected cellulitis and vascular occlusion are addressed in the label.
 
Event Description
A physician reported via a sales representative that a (b)(6) year old female received radiesse+ in the chin.Medical history included prior radiesse and hyaluronic acid fillers.Concomitant products were not reported.In (b)(6) 2015, approximately 7 days prior to report, the physician injected 1.5cc radiesse+ as three boluses to the chin.The next day, symptoms of discoloration and pain developed.On day 2, the patient was prescribed doxycycline.On day 3, pustules developed.The patient consulted with a dermatologist who suspected cellulitis and changed antibiotics (later identified as cephalexin).At the time of this report, the patient has a "pink patch" 3cm x 4cm with dark discoloration in the center.The physician referred patient for a plastic surgery consult and the plastic surgeon diagnosed a vascular occlusion.Additional information was received from the physician on (b)(6) 2016: the physician stated that patient was treated with local wound care, aquaphor, and aspirin.The area was still pink but "looks very good.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RADIESSE+ DERMAL FILLER
Type of Device
INJECTABLE IMPLANT
Manufacturer (Section D)
MERZ NORTH AMERICA
4133 country road
franksville WI 53126
Manufacturer (Section G)
MERZ NORTH AMERICA
4133 country road
franksville WI 53126
Manufacturer Contact
scott sykes, md
6501 six forks road
raleigh, NC 27615
9195828000
MDR Report Key5358379
MDR Text Key35607734
Report Number2135225-2016-00001
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P050052
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 12/16/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/16/2015
Initial Date FDA Received01/11/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age27 YR
-
-